SIT Graduate Institute/SIT Study Abroad

SIT Digital Collections
Independent Study Project (ISP) Collection

SIT Study Abroad

Fall 2013

Gender Disparities in Access to HIV Testing and
Antiretroviral Treatment Services
Wyatt Lombard Smith
SIT Study Abroad

Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection
Part of the Family, Life Course, and Society Commons, Health Policy Commons, Health Services
Administration Commons, Immune System Diseases Commons, Inequality and Stratification
Commons, Medicine and Health Commons, and the Public Health Education and Promotion
Commons
Recommended Citation
Smith, Wyatt Lombard, "Gender Disparities in Access to HIV Testing and Antiretroviral Treatment Services" (2013). Independent
Study Project (ISP) Collection. 1687.
https://digitalcollections.sit.edu/isp_collection/1687

This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for
inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please
contact digitalcollections@sit.edu.

Gender Disparities in Access to
HIV Testing and Antiretroviral
Treatment Services

Wyatt Lombard Smith

Project Advisor: Dr. Paul Muwanguzi
Academic Director: Dr. Charlotte Mafumbo
School for International Training
University of Notre Dame
Kampala, Uganda
Naggalama, Uganda
Fall 2013

1

Table of Contents
ACKNOWLEDGEMENTS............................................................3
ABSTRACT……………………………………………………………………..4
ABBREVIATIONS…………………………………………………………….6
INTRODUCTION……………………………………………………………..7
BACKGROUND……………………………………….……………………….8
HIV/AIDS IN UGANDA………………………………………………………………8
ANTIRETROVIRAL TREATMENT……………………………………………….10
MALE CIRCUMCISION PROGRAMS……………………………………………13

JUSTIFICATION…………………………………………………………....14
STATEMENT OF OBJECTIVES………………………………………...14
METHODOLOGY......................................................................15
OVERVIEW........................................................................................................15
STUDY POPULATION AND SAMPLING.......................................................15
INCLUSION AND EXCLUSION......................................................................16
VARIABLES.......................................................................................................17
PROCEDURE.....................................................................................................18
OBSERVATION.................................................................................................18
FOCUS GROUP DISCUSSIONS......................................................................19
FORMAL AND INFORMAL INTERVIEWS....................................................19
STATISTICAL ANALYSIS................................................................................20
CHALLENGES AND BIASES...........................................................................21
STATEMENT OF ETHICS................................................................................22

RESULTS.................................................................................23
MORTALITY......................................................................................................23
DIFFERENCES IN MORTALITY EXPLAINED BY LATE INITIATION.....25

FINDINGS AND DISCUSSION.................................................28

REASONS AND MOTIVES FOR HIV TESTING............................................29
ANTIRETROVIRAL TREATMENT SERVICES..............................................31
MALE CIRCUMCISION PROGRAMS.............................................................33
RURAL VS. URBAN COMPARISON................................................................35

CONCLUSIONS........................................................................36
RECOMMENDATIONS.............................................................38
BIBLIOGRAPHY......................................................................41
APPENDIX..............................................................................43

2

Acknowledgements
I would like to thank Dr. Charlotte Mafumbo for her never-ending guidance and
support on this project. This project would not have been possible without her wisdom
and generosity throughout this entire program. I would also like to thank the staff at The
AIDS Support Organisation (TASO) and St. Francis Naggalama Hospital for their
knowledge and outstanding facilities. I would like to thank Dr. Simon Sentumbwe for his
input and support in this project and I would also like to thank my interpreters for an
incredible job in eliminating the language barrier between the participants and the
researcher. Finally, I would like to extend thanks to Dr. Paul Muwanguzi for his
continuous input and support as my Academic Advisor and guide during this practicum
period.

3

Abstract
Throughout a six-week practicum period at TASO Mulago in Kampala, Uganda
and St. Francis Naggalama Hospital in Naggalama, Uganda, the researcher aimed to find
methods to increase male engagement in all facets of comprehensive HIV/AIDS care.
Women and children generally receive most global attention on the issue of HIV/AIDS in
Uganda but men are beginning to demand more attention. Antiretroviral treatment has
been critical in allowing countless people to live functionally with HIV but many
research projects have hypothesized that delayed access to HIV/AIDS treatment and
prevention methods has resulted in men exhibiting higher mortality rates upon initiation
of this treatment. The disparity in men’s reception to this treatment puts the effectiveness
of this and many other aspects of comprehensive HIV/AIDS treatment into question.
Through statistical analysis, observation, formal and informal interviews, and
focus group discussions the researcher aimed to test the hypotheses that men are much
more likely to die when they initiate antiretroviral treatment than women and that this
higher mortality rate results from later initiation of treatment characterized by CD4 cell
count and WHO disease stage number. Through statistical analysis the researcher
established the mortality rate as 16.485 deaths per 1000 men and 11.13 deaths per women
at TASO Mulago and 69.444 deaths per 1000 men and 23.809 deaths per 1000 women at
St. Francis Naggalama Hospital, proving the hypothesis that men have a higher mortality
rate upon initiation of ART. Significant differences in CD4 cell counts and WHO disease
stage numbers proves the hypothesis that this higher mortality rate is a result of later
initiation of ART.
Through qualitative data the researcher found that women are required to test for
HIV at early signs of pregnancy and through antenatal care but men have no similar
avenue to test for HIV and as a result they only test for HIV as a result of grave illness
brought about by a weakened immune system characteristic of high HIV prevalence. Men
are also highly stigmatized by social forces that further exaggerate gender differences in
access to HIV/AIDS care and support. The researcher proposes enhanced male
circumcision programs to serve as avenues for men to engage in all facets of
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comprehensive HIV/AIDS care. Through these programs men would gain education and
encouragement to join in the fight against this epidemic.
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Introduction
On their website, UNAIDS defines their program as “an innovative partnership
that leads and inspires the world in achieving universal access to HIV prevention,
treatment, care and support.1” The values established in this statement are critical in
combating the prevalence of this virus and syndrome from our planet and for the country
of Uganda these values must be swiftly implemented to create change on this issue. Much
global research and attention has been directed to the problem of HIV/AIDS in Uganda
but this condition continues to threaten the health and well being of many of the citizens
of this country. Much of this attention is directed towards mothers and children,
especially in the prevention of mother to child transmission of this virus (PMTCT).2
While women and children are generally considered more vulnerable, men also play a
significant role in the spread of HIV/AIDS and are starting to demand more attention on
this matter.
Antiretroviral therapy, defined as “the combination of at least three
antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression
of HIV disease,” has allowed many individuals infected with the human
immunodeficiency virus to live functional lives despite the tragic effects that this virus
can pose on the human body3. Current research dictates, however, that men are beginning
to exhibit higher mortality rates upon initiation of antiretroviral treatment than women.4
This hypothesis is driven by the notion that men begin treatment later than women,
resulting in a higher prevalence of the human immunodeficiency virus and a lower
1

UNAIDS. (2012) About UNAIDS. Retrieved from
UNICEF. (2013 September 5) Children and HIV and AIDS. Retrieved from
http://www.unaids.org/en/aboutunaids/
http://www.unicef.org/aids/index_preventionyoung.html
2

3

WHO. (2013) Antiretroviral therapy. Retrieved from

http://www.who.int/hiv/topics/treatment/art/en/index.html
4

Mills, E., Beyrer, C., Birungi, J., & Dybul, M. (2012 February 7). Engaging Men in

Prevention and Care for HIV/AIDS in Africa. PLOS Medicine. Retrieved from
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001167
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prevalence of CD4 cells, the cells essential for a functioning immune system. Universal
access to HIV treatment and prevention can only be accomplished by greater involvement
of men in these practices that have been successful in reducing the prevalence of
HIV/AIDS and helping people live functionally with HIV. Targeting men in the fight
against HIV/AIDS is critical to combating HIV transmission and infection in Uganda and
eliminating HIV/AIDS from Uganda requires a holistic approach including focus on men,
women, and children together.
This project sought to test the hypotheses that men have a higher mortality rate
than women upon initiation of antiretroviral treatment and that men begin antiretroviral
treatment at later stages of HIV infection than women. This project also studied the
effects of this lack of attention towards men in Uganda further to propose methods to
further include men in the scope of global research to holistically combat the prevalence
of HIV/AIDS in this country. The researcher conducted this study in TASO Mulago in
Kampala, Uganda and St. Francis Naggalama Hospital in Naggalama, Uganda from
October 21, 2013 to December 1, 2013 over a six-week period to compare how these
issues are addressed in rural and urban settings. The study used qualitative data from
focus group discussions, formal and informal interviews, and field observations as well as
quantitative data from the databases of TASO Mulago and St. Francis Naggalama
Hospital.

Background
HIV/AIDS in Uganda
According to statistics presented by UNAIDS in 2012, approximately 7.2% of
the population of Uganda currently lives with the human immunodeficiency virus and
approximately 150,000 people in Uganda become infected with HIV every year. These
statistics also estimate that 62,000 people die from complications of AIDS in Uganda
every year5. According to the 2011 Uganda AIDS Indicator Survey, HIV is most
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UNAIDS. (2012). HIV and AIDS Estimates in Uganda Retrieved from

http://www.unaids.org/en/regionscountries/countries/uganda/
8

prevalent in the Central 1 region (10.6%) and the Central 2 region (9.0%).6 The map in
the appendix illustrates this data further (see appendix A). TASO Mulago is located in an
urban setting in Kampala, Uganda, receiving clients from the Central 1 Region and St.
Francis Naggalama Hospital is located in a rural setting in the Mukono District and
receives clients from the Central 2 region. The researcher carried out his study at these
two facilities to compare how antiretroviral treatment is administered in rural and urban
settings and to gain a more holistic understanding of the problem of HIV/AIDS in the
regions exhibiting the highest HIV prevalence.
In the past many HIV/AIDS strategies addressed either prevention or treatment
of this epidemic, but recent data suggests that comprehensive care in which treatment and
prevention work together provides the best strategy for decreasing the presence of
HIV/AIDS in Uganda (see Appendix B).7 According to Uganda’s progress report “The
epidemic is still predominantly heterosexually transmitted with 80% of infections
attributable to heterosexual transmission. Mother to child transmission accounts for 20%
while blood borne and other infections account for less than 1%.8” Despite these figures,
most research focuses on PMTCT but men bear just as much responsibility as women in
this battle against HIV/AIDS. In Uganda, men often engage in polygamous practices
more than women and engage in more risky lifestyle habits. While many argue that these
factors play no significant role in HIV transmission, research on this matter indicates,
“Sharp increases in monogamy also contributed to lowering the risk for HIV infection or
6

UAIS (2011). 2011 Uganda AIDS Indicator Survey. Retrieved from

http://health.go.ug/docs/UAIS_2011_FACT_SHEET.pdf
7

Salomon, J. A., Hogan, D. R., Stover, J., Stanecki, K. A., Walker, N., Ghys, P. D., &

Schwartländer, B. (2005). Integrating HIV prevention and treatment: from slogans to
impact. PLoS Medicine, 2(1), e16.
8

UNAIDS. (2013). Global AIDS Response Progress Report: Uganda Jan 2010-Dec 2012.

Retrieved from
http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012co
untries/ce_UG_Narrative_Report[1].pdf
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the periods 1989-1995 and 1995-2000. These increases reduced the risk for HIV infection
among younger married and among unmarried sexually active women at all ages.9” These
polygamous relationships can lead to a network of transmission between multiple women
and children and ultimately, the risky lifestyles of men result in the transmission of HIV
to all groups whether they are deemed vulnerable or not. Men’s role in the transmission
of HIV/AIDS is often ignored but to eradicate this condition, their presence must be
addressed more thoroughly. Lack of attention towards men in HIV/AIDS care strategies
has left a significant impact on many of the other methods of comprehensive care,
especially antiretroviral treatment.

Antiretroviral Treatment
Antiretroviral treatment generally helps those individuals infected with HIV to
live a healthy life but research indicates that men are more likely to die upon initiating
antiretroviral treatment than women. Much of the HIV/AIDS research in Uganda focuses
on women and children because they are generally viewed as vulnerable groups but the
role of men in the prevalence and transmission of HIV/AIDS often receives less attention.
Yet, approximately 530,000 men above the age of 15 currently live with HIV in Uganda
suggesting that men do play a significant role in the spread and transmission of
HIV/AIDS and focusing on men is critical to aiding in the fight against HIV/AIDS in this
country. The impact of this lack of attention directed towards men in the fight against
HIV/AIDS in Uganda will be investigated through the following literature survey. It is
hypothesized that lack of focus on men results in a higher mortality rate for men
beginning antiretroviral treatment than women because they generally start treatment at
lower CD4-cell counts. Research has suggested that lack of attention towards men in the
fight against HIV/AIDS creates fewer opportunities for men to receive provider-initiated
HIV testing while women go through provider-initiated testing at early signs of
pregnancy and in the midst of antenatal care. The following articles demonstrate and
support this hypothesis as background for this study, which aims to determine whether
9

Singh, S., Darroch, J. E., & Bankole, A. (2004). A, B and C in Uganda: The roles of
abstinence, monogamy and condom use in HIV decline. Reproductive Health
Matters, 12(23), 129-135.
10

lack of opportunity for provider-initiated HIV testing for men in Uganda contributes to
the disparity in mortality rate between men and women initiating antiretroviral treatment
and to propose methods to incorporate more provider-initiated HIV testing for men into
Uganda’s healthcare system.
In “The first decade of antiretroviral therapy in Africa,” Ford et. al discuss the
global effort to decrease the cost accessibility of antiretroviral therapy in developing
countries. Initially, efforts to invest in antiretroviral treatment were not viewed as costeffective because the cost was unaffordable for the average individual in a developing
country as well as the fact that prevention was viewed as a superior form of combating
HIV/AIDS than treatment. Experts from all over the world urged that those living with
HIV should be able to live a healthy life rather than a race to their death. Global effort
effectively lowered the cost of this treatment allowing individuals in developing countries
in Africa to gain access. The article urges that starting treatment earlier results in greater
survival among patients and that greater antiretroviral treatment coverage can help
decrease transmission of HIV. The authors insist “efforts are needed to reinforce the
treatment cascade all along the pathway from HIV testing to early initiation to lifelong
adherence to treatment10”. This article highlights the importance of antiretroviral
treatment and urges that early adherence to the treatment is essential to survival.
Therefore, this article justifies the focus on antiretroviral treatment for this study and
provides background to the hypothesis that men start antiretroviral treatment later than
women, leading to a higher mortality rate for men upon initiating this treatment.
In “Expanding HIV care in Africa: making men matter,” the authors discuss all
the efforts made to provide women with HIV treatment before stating that far more
women than men receive antiretroviral treatment. The article states “men appear to enter
cARTprogrammes at a more advanced clinical stage and, as a consequence, mortality
rates are higher in men11”. The article also urges “in many countries antenatal care
services provide an important entry point to HIV/AIDS testing and treating, which
10

Ford, N., Calmy, A., & Mills, E. J. (2011). The first decade of antiretroviral therapy in
Africa. Global Health, 7(1), 33-33.
11

Mills, E. J., Ford, N., & Mugyenyi, P. (2009). Expanding HIV care in Africa: making
men matter. The Lancet, 374(9686), 275-276.
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creates a particular opportunity for women to access care. Similar access points do not
exist for men, although circumcision programmes, if expanded, would provide such an
opportunity in the future8”. This article supports the hypothesis that men do have a higher
mortality rate upon initiation of treatment because of a lack of opportunity for providerinitiated testing. The article also suggests circumcision programs as potential methods of
implementing this level of HIV testing for men, which will be expanded upon further in
this project.
In “Male gender predicts mortality in a large cohort of patients receiving
antiretroviral therapy in Uganda,” the authors specify that the findings of the previous
article are relevant to the country of Uganda. They state that men in Uganda have less
access to HIV/AIDS care than women, creating a higher mortality rate for men beginning
antiretroviral treatment. Finally, the article urges that gender sensitive antiretroviral
treatment would maximize the benefits of this treatment for the country of Uganda12.
Also, in “Increased mortality among HIV-positive men on antiretroviral therapy: survival
differences between sexes explained by late initiation in Uganda” the authors provide
statistical analysis that prove the disparity in mortality rate between genders is caused by
late initiation of treatment as a result of a lack of access to HIV/AIDS care and providerinitiated testing. These articles support the hypothesis that incorporating more providerinitiated testing for men in the healthcare system would lead to greater efficiency of
antiretroviral treatment in Uganda13. The following section will highlight past efforts to
incorporate circumcision programs into comprehensive HIV/AIDS care strategies to gain
an understanding of their effectiveness in providing the citizens of Uganda with universal
access to all forms of HIV/AIDS care and support.
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Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Hogg, R. S., Ford, N., ... & Cooper, C.
L. (2011). Male gender predicts mortality in a large cohort of patients receiving
antiretroviral therapy in Uganda. Journal of the International AIDS Society, 14(1), 52.
13
Kanters, S., Nansubuga, M., Mwehire, D., Odiit, M., Kasirye, M., Musoke, W., ... &
Mills, E. J. (2013). Increased mortality among HIV-positive men on antiretroviral
therapy: survival differences between sexes explained by late initiation in
Uganda. HIV/AIDS (Auckland, NZ), 5, 111.
12

Male Circumcision Programs
Male circumcision programs have the potential to significantly reduce the
prevalence of HIV/AIDS in Uganda in multiple ways. First of all, the act of circumcision
for men significantly reduces the risk of contracting HIV from penile-vaginal sex.14
Based on this information, many organizations have initiated a “safe male circumcision”
campaign across the country in an effort to “contribute to the reduction in HIV and other
Sexually Transmitted Infections incidences through increased safe male circumcision
uptake.15” The majority of the population of Uganda remains uncircumcised so proper
implementation of this program can make an impact on the prevalence of HIV/AIDS in
Uganda. Despite the potential of this program to affect the health and well being of the
citizens of Uganda, news sources state, “The UAC acknowledges that, since the
programme's launch in 2010, it has not been formally scaled-up nationally, and effective
linkages between SMC and other HIV services have not been put in place.16” Lack of
funding and coordination from the Ugandan Government effectively limits the potential
of these programs and campaigns.
These programs not only can reduce the risk of HIV transmission during sex but
also can create an avenue for men to engage in more provider-initiated testing and
treatment for HIV/AIDS. Many hospitals and facilities have used antenatal clinics as
effective methods of provider-initiated HIV/AIDS testing and care for women and these
circumcision programs can be used as similar ways of engaging men in provider-initiated
testing as well. This study seeks to further evaluate the effectiveness of these programs in
engaging more men in provider-initiated treatment. Male engagement in comprehensive
14

Centers for Disease Control and Prevention. (2013, April 15). Male Circumcision.

Retrieved from http://www.cdc.gov/hiv/prevention/research/malecircumcision/
15

National Communication Strategy. (2010). Safe Male Circumcision for HIV

Prevention. 1-34.
16

IRIN news (2012 November 6). UGANDA: Mixed progress in male circumcision

campaign from http://www.irinnews.org/report/96725/uganda-mixed-progress-in-malecircumcision-campaign
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HIV/AIDS care strategies could potentially decrease the gender disparities in access to all
forms of HIV/AIDS care and support. Universal access to treatment and support is
possible but proper implementation and support by the Ugandan Government is critical in
this idea becoming reality.

Justification
Efforts to eradicate HIV/AIDS from the country of Uganda have been very
effective, but studies show that a lack of attention towards the treatment of HIV/AIDS for
men has reduced the effectiveness of treatment and prevention for the country of Uganda.
This study focuses on men in an attempt to reduce and eliminate the disparity in mortality
rate between men and women initiating antiretroviral treatment, thus increasing the
effectiveness of antiretroviral treatment within the entire country. This study also plans
on comparing HIV/AIDS efforts of hospitals in urban and rural settings to gain a holistic
perspective on HIV/AIDS treatment and prevention strategies in Uganda. Providing men
with more provider-initiated testing has been hypothesized to reduce this disparity and
this study aims to test this hypothesis and propose methods in which HIV testing may
become more common for men. Focusing on men in the fight against HIV/AIDS is a
critical step in eliminating the prevalence of the human immunodeficiency virus within
the entire population and this study aims to provide that focus.

Statement of Objectives
The objectives of this study include:
1. To assess if there are gender differences in access to HIV testing and
antiretroviral treatment services
2. To further examine the causes of disparities between men and women in access to
HIV prevention and treatment
3. To establish the differences in mortality rate between men and women upon their
initiation of antiretroviral treatment
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4. To compare HIV treatment, counseling, and antiretroviral treatment services for
men in urban and rural facilities in Uganda
5. To propose methods to increase opportunities for men to engage in providerinitiated HIV testing.
This study will be driven by two hypotheses;
1. Men have a higher mortality rate than women upon initiating antiretroviral
treatment.
2. Men initiate antiretroviral treatment at later stages of HIV infection than women.

Methodology
Overview
This study was conducted from October 24, 2013 until December 1, 2013 over a
six-week practicum period. The researcher spent the first three weeks at TASO Mulago
while spending the remaining three weeks in St. Francis Naggalama Hospital in Mukono
District to compare how comprehensive HIV/AIDS care is administered and received in
an urban setting and a rural setting. The researcher used observation, interview, focus
group discussions, and statistical analysis to gather qualitative and quantitative data.

Study Population and Sampling
For qualitative analysis, the researcher interviewed 52 men and 76 women at
TASO Mulago in the form of focus group discussions. The researcher received
participants randomly from client liaisons, former clients of TASO who have seen vast
improvement in their lives as a result of antiretroviral therapy. These liaisons were
instructed to provide the researcher with gender-exclusive and gender-mixed groups of
individuals age 18 or older who currently engage in antiretroviral therapy. At St. Francis
Naggalama Hospital the researcher interviewed 19 men and 23 women using focus group
discussions. The Director of Data Collection at St. Francis Naggalama Hospital chose
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these groups randomly under the same inclusion and exclusion principles stated earlier.
The researcher accumulated participants until the data collected reached a saturation
point in which no new answers were recorded.
For quantitative analysis, the researcher used the electronic records at TASO
Mulago to accumulate participants who have started antiretroviral therapy from January
2011 to June 2013. To establish the mortality rate at TASO Mulago, the researcher
accumulated data from all 43,158 clients initiating ART at TASO since their
implementation of ART into their HIV/AIDS care strategy. The researcher used existing
data sets to augment this study. These dates were chosen to represent the population of
TASO clients that recently initiated antiretroviral treatment to create a sample size of 903
men and 2,355 women. When analyzing CD4 cell count, the researcher filtered out all
clients who did not possess a value for CD4 cell count within 6 months before initiation
of ART, leaving the sample size for CD4 cell count analysis at 384 men and 960 women.
St. Francis Naggalama Hospital did not possess any electronic record system and as a
result of time constraints, the researcher could not accumulate data from every client
initiating antiretroviral treatment from January 2011 to June 2013. As a result the
researcher used Farum’s 1997 formula of calculating sample size, which states that
Sample size= N/ (1 +Ne2)
Where N is the accessible population
And e is the level of significance (0.05)
The Director of Data Collection at St. Francis Naggalama Hospital estimated that 600
clients 18 years and older have initiated antiretroviral therapy between the dates of
January 2011 to June 2013. Using this number as the accessible population, the
researcher randomly sampled participants from patient files in the hospital’s data room to
reach a sample size of 240 participants.

Inclusion
The participants included in this study must be 18 years or older and must have
initiated antiretroviral treatment.
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Exclusion
Participants under the age of 18 as well as participants who have not initiated
antiretroviral treatment were excluded from this study.

Variables
In focus group discussions, the researcher explored variables including
occupation, gender, marriage status, motivations for HIV testing, perceptions of HIV
testing, perceptions of antiretroviral therapy, challenges of engaging in antiretroviral
therapy, and perceptions of male circumcision to gain a greater understanding of cultural
and social factors responsible for men’s lack of engagement in comprehensive HIV/AIDS
care. The interview schedule used in these focus group discussions has been appended
here in Appendix C (See Appendix C). In semi-structured interviews with various
healthcare professionals, the researcher sought to gain a better understanding of gender
differences in reception of sensitization strategies, perceived effectiveness of
antiretroviral therapy as a treatment strategy, and perceived impact of circumcision
programs as methods of increasing male engagement in provider-initiated HIV testing.
Variables measured in quantitative analysis include gender, age at initiation of
antiretroviral therapy, CD4 cell count at initiation of antiretroviral therapy, WHO disease
stage at initiation of antiretroviral therapy, and mortality after initiation of antiretroviral
therapy. These variables were measured to test the hypothesis that men have a higher
mortality rate upon initiation of antiretroviral treatment as a result of delayed access to
comprehensive HIV/AIDS care and provider-initiated testing and counseling. CD4 cell
count represents the strength of the immune system and typically ranges from 500-1000
cells/mm.3 A client with a CD4 cell count value of less than 350 cells/mm3 should begin
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antiretroviral treatment.17 WHO disease stage numbers range from 1 to 4. Full
descriptions of each clinical stage can be found in the appendix (See Appendix D)18.

Procedure
The methods of focus group discussion, formal and informal interviews,
observation and statistical analysis will be expanded upon and discussed in the following
sections.

Observation
The researcher used observation to better understand and compare how TASO
Mulago and St. Francis Naggalama Hospital each administered HIV/AIDS care and
support based on setting and location. The researcher used this method of data collection
to set a critical foundation for the facilitation and operation of other data collection
methods. Observation strengthened the questionnaires and interview schedules used to
acquire data in focus group discussions and formal and informal interviews. These other
methods of data collection supplemented various observations noted by the researcher.
Observation included noting clinic days, observing the ratio of male to female patients
receiving antiretroviral therapy, examining the processes that clients experienced to
receive treatment, and identifying the procedure that each facility followed in their
administration of HIV/AIDS care. Through observation the researcher was able to
properly implement the following data collection methods to gain a holistic
understanding of antiretroviral treatment administration and reception in a rural and
urban setting.

17

AIDS.gov. (2010 October 11). CD4 Count. Retrieved from http://www.aids.gov/hiv-

aids-basics/just-diagnosed-with-hiv-aids/understand-your-test-results/cd4-count/
18

World Health Organization. (2005 February). INTERIM WHO CLINICAL STAGING

OF HIV/AIDS AND HIV/AIDS CASE DEFINITIONS FOR SURVEILLANCE.
Retrieved from http://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf
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Focus Group Discussions
In the interest of time, the researcher used focus group discussions in groups of 57 participants to reach a substantial number of participants initiating antiretroviral
treatment ages 18 and older. The groups were mostly a mixture of men and women but
groups of all men and all women were included to eliminate group dynamics as a variable
for how responses were given. A standard interview schedule was used to better compare
the answers provided by each focus group. The researcher hired an interpreter at each
facility to eliminate the language barrier between the researcher and the participants. The
interpreter at TASO Mulago was chosen by the facility to help provide an interpreter that
had significant knowledge of the problem of HIV/AIDS in Uganda. The Director of Data
Collection at St. Francis Naggalama Hospital served as the interpreter for focus group
discussions facilitated at Naggalama. The researcher recorded every focus group
discussion with an electronic recording device and transcribed the responses later while
the interpreter asked the questions provided by the researcher in the local language. Every
discussion began with a general introduction to the purpose of the study and all
participants were informed that all answers were anonymous and not mandatory.

Formal and Informal Interviews
The researcher conducted interviews with selected healthcare professionals to
gain as much knowledge from each individual as possible. Interviews were semistructured in which the majority of questions previously prepared and some questions
were created on the spot as a result of certain responses. Interview schedules for each of
these interviews can be found in the appendix (see appendix E). Participants were chosen
to represent all aspects of comprehensive HIV/AIDS care including antiretroviral
medication and therapy, counseling, community sensitization, and circumcision
programs. An interview with an HIV/AIDS counselor at TASO Mulago on November 7,
2013 helped the researcher contextualize community sensitization and counseling
services while analyzing the effectiveness of these strategies on each gender. On
November 8, 2013 Dr. Simon Sentumbwe, a physician and researcher of HIV/AIDS in
Uganda provided great insight to issues concerning research and administration of
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comprehensive HIV/AIDS care strategies as well as engaging men in circumcision
programs. Also on November 8, 2013 a nurse at the safe male circumcision clinic
sponsored by Makerere University in Kampala, Uganda was interviewed to provide
insight to the manner in which the clinic recruits clients as well as how the clinic
operates. Finally, a pharmacist at St. Francis Naggalama Hospital was interviewed on
November 19, 2013 to gain a better perspective of the efficiency and effectiveness of
antiretroviral medication. These interviews were supplemented with various informal
interviews throughout the duration of the study. Overall, these interviews augmented and
validated the information received from participants in focus group discussions and
provided a better understanding of all facets of comprehensive HIV/AIDS care strategies.

Statistical Analysis Using ANOVA Chi-Squared Test
For the quantitative aspect of this study, the researcher used Analysis of Variance
(ANOVA) to test the hypothesis that the higher mortality rate exhibited by men at their
initiation of antiretroviral treatment is attributed to later initiation measured by initial
CD4 cell count and initial WHO disease stage. Analysis of variance was used to quantify
the statistical significance that gender had on CD4 cell count (measured in cells/mm3) at
initiation of antiretroviral treatment. The analysis used the mean values of CD4 cell
counts for men and women at ART initiation. Data recorded from patient files are
accurate within six months of initiating ART. P values less than 0.05 were considered
significant. All data was collected from the electronic databases of TASO Mulago and
from patient files from St. Francis Naggalama Hospital. All analysis was conducted using
STATA, a data analysis and statistical software. The mortality rate of those individuals
aged 18 or older who have initiated ART anytime within January 2011 to June 2013 was
calculated using the following formula.
𝑅=

𝑥
10!
𝑡

Where R is the Mortality Rate
x is number of dead clients
t is the total population sampled
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These dates were chosen to represent those recently initiating treatment while
allowing for 6 months of progression on the treatment regime. The rate estimates the
number of clients dead per 1000 clients. At St. Francis Naggalama Hospital, mortality
was not recorded in patient files. Therefore, the researcher deemed those patients who
have not returned to the facility within six months of their follow-up date as lost to follow
up. The researcher also inferred that 30% of patients lost to follow up were dead,
following the procedure of other studies conducted within the same subject matter in
Uganda.19
Finally, the researcher used a Chi-Squared Test to establish the statistical
significance of these established mortality rates and to identify the statistical significance
of collected WHO disease stage numbers at ART initiation. The Chi-Squared test was
used based on the null hypothesis that men and women should have the same mortality
rate upon initiation of ART. This test provides a probability that a difference in mortality
rate is statistically significant or due to chance. P-values smaller than 0.05 were
considered significant. The Chi-squared test was also used to test the null hypothesis that
men and women should initiate ART at the same WHO disease stages. The probability
value resulting from this test will determine whether differences in WHO disease stages
numbers between men and women initiating ART were due to chance or statistically
significant. P-values smaller than 0.05 were considered significant.

Challenges and Biases
Each method the researcher used played a great role in the accumulation of data
necessary for this project but all data collection methods provide challenges and biases.
Observations can incorporate a researcher’s personal biases into the data collected and as
a result the researcher attempted to supplement all data collected from observations with
formal and informal interviews and focus group discussions.
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Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., ... & Hogg, R.
S. (2011). Life expectancy of persons receiving combination antiretroviral therapy in
low-income countries: a cohort analysis from Uganda.Annals of internal
medicine, 155(4), 209-216.
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The researcher selected interpreters with a vast knowledge of the subject matter
and sometimes interpreters would analyze information rather than translate it, resulting in
concise, summarized responses rather than full responses. This may have resulted in
personal bias in some of the responses recorded from the focus group discussions as well
as some missing information. Use of interpreters also forces the researcher to rely on the
interpreters providing correct responses to ensure valid collected data.
Mortality is rarely recorded at TASO Mulago because client contacts may not
communicate the death of a client to the facility that was providing the client treatment.
Therefore the electronic records from TASO Mulago may not represent every individual
who has died after initiating ART but this outside factor should affect men and women
clients equally. Therefore, the data collected by the researcher equally represents the men
and women who are clients at TASO Mulago and St. Francis Naggalama Hospital. Also,
substantial differences in sample size may distort the researcher’s ability to compare
statistics at each facility. The researcher relied on Farum’s 1997 formula to provide
justification for proper representation of clients recently initiating ART at St. Francis
Naggalama Hospital to allow proper comparison to statistics from TASO Mulago.

Statement of Ethics
The researcher of this study conducted all research in an ethical manner.
Permission to conduct this preliminary study was provided by TASO Mulago and St.
Francis Naggalama Hospital and the investigator adhered to all the ethical conduct
required in this exercise. More specifically, all respondents shall remain anonymous and
the researcher shall not publish any responses to survey, focus groups, or interviews
without written consent from TASO, St. Francis Naggalama Hospital, or the respondents.
The results gathered from this study are presented as accurately as possible without bias
or manipulation. Most of all, the researcher attempted to respect and honor the rules and
philosophies of the facilities used as well as respect and honor the participants of this
study. Follow up permission has been granted by the Uganda National Council for
Science and Technology body through the School for International Training Research
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Model 3. Consent forms used during the key informant interviews have been appended
under Appendix F (see Appendix F).

Results
Mortality
The researcher sought to test two hypotheses with this study. The researcher
established the mortality rate for men and women at TASO Mulago and St. Francis
Naggalama Hospital to test the hypothesis that men exhibit a higher mortality rate than
women upon initiation of antiretroviral treatment. Furthermore, the researcher used
statistical analysis to test the hypothesis that this higher mortality rate can be attributed to
delayed access to provider-initiated HIV/AIDS care for men. Using baseline CD4 cell
counts, baseline WHO disease stage numbers, and measuring all-cause mortality, the
researcher conducted the same analysis at each facility as a means of greater
representation for the Central 1 and Central 2 regions of Uganda, the regions with the
highest prevalence of HIV/AIDS, while comparing urban and rural facilities.
Based on all 43,158 clients initiating ART at TASO Mulago (14,316 men and
28,842 women) 236 men and 321 women were recorded as dead resulting in a mortality
rate of 16.485 deaths per 1000 male clients and 11.130 deaths per 1000 female clients.
These results suggest that men have a higher mortality rate than women upon initiation of
antiretroviral treatment at TASO Mulago. The following table highlights this data.
Table 1. Mortality Rate of Male and Female Patients at TASO Mulago20
	
  	
  
Male	
  
%	
  
Dead	
  
236	
  
Total	
  
14316	
   	
  
Mortality	
  Rate	
  
16.485	
   	
  	
  

20

Female	
  
%	
  
1.65	
  
321	
  
1.11	
  
28842	
   	
  	
  
11.13	
   	
  	
  

Data collected by the researcher from electronic records at TASO Mulago
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At St. Francis Naggalama Hospital, the researcher analyzed 240 clients (72 men
and 168 women) for mortality but mortality was not recorded in patient records. As a
result, the researcher tracked those patients lost to follow up and assumed 30% of patients
lost to follow up had died. 13 women and 18 men were lost to follow up, resulting in an
estimation that 4 women and 5 men had died since their initiation of ART. Using the
same protocol, the researcher established that the mortality rate for men is approximately
69.444 deaths per 1000 clients initiating ART at St. Francis Naggalama Hospital and for
women the rate is approximately 23.809 deaths per 1000 clients initiating ART at this
hospital. This is highlighted in the following table.
Table 2. Mortality Rate of Male and Female Patients at St. Francis Naggalama Hospital21
	
  
Dead	
  	
  
Total	
  
Mortality	
  Rate	
  
	
  

Male	
  

	
  

%	
  

5	
  
72	
   	
  
69.444	
   	
  
	
  

Female	
  
6.94	
  

	
  

%	
  

4	
  
168	
   	
  
23.809	
   	
  
	
  

2.38	
  

To establish the statistical significance of these mortality rate values, the
researcher utilized a chi-squared test to determine the probability that men’s higher
mortality rate was based on chance. According to the null hypothesis, men should have
the same mortality rate as women at both facilities. Therefore men should have a
mortality rate of 11.130 deaths per 1000 clients, the same rate as women at TASO
Mulago and 23.809 deaths per 1000 clients, the same rate as women at St. Francis
Naggalama Hospital. Based on this null hypothesis, approximately 159 men should have
died rather than 236 at TASO Mulago and approximately 2 men should have died rather
than 5 at St. Francis Naggalama Hospital. Considering data with a p-value less than 0.05
as statistically significant, the test resulted in p-values less than 0.0001 and 0.01 at TASO
Mulago and St. Francis Naggalama Hospital respectively. Therefore, these values were
compared to find that men’s observed mortality rate is significantly higher than that for
women at both facilities. The results from both facilities have been summarized in the
following table. The causes for this significant difference will be explored in detail in the
following section.
21

Data collected by the researcher from patient files at St. Francis Naggalama Hospital
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Table 3. Results of Chi-Squared Test of Mortality Rate22
Sample	
  

Variable	
   Observed	
  #	
   Expected	
  #	
   Chi-‐Squared	
   dF	
   p-‐value	
  
Value	
  
Dead	
  
236	
  
158.9076	
  
37.82	
   1	
   p<0.0001	
  

TASO	
  
Mulago	
  
	
  
Alive	
  
St.	
  Francis	
   Dead	
  	
  
Naggalama	
  
	
  
Alive	
  

14080	
   14157.0924	
   	
  
5	
  
1.7136	
  
67	
  

70.2864	
   	
  

	
  
6.456	
  
	
  

	
  
1	
   p=<0.0111	
  
	
  

Differences in Mortality Explained by Late Initiation
The researcher tested the second hypothesis that men’s higher mortality rate upon
initiation of ART is a result of a later initiation by gathering CD4 cell counts and WHO
disease stage numbers from clients at TASO Mulago and St. Francis Naggalama Hospital
at their initiation of ART. These values represent the condition of the client at their ART
initiation and their timing of care. A lower CD4 cell count and a higher disease stage
number are both characteristics of later initiation and greater prevalence of the human
immunodeficiency virus within the human body.
At TASO Mulago 1,344 people possessed a baseline CD4 cell-count upon
initiation of ART between January 2011 and June 2013 (384 men and 960 women). The
average CD4 cell count for men at this facility was 250.3 cells/mm3 and the average for
women was 317.6 cells/mm3. Using one-factor ANOVA to analyze the statistical
significance of this difference, the researcher found a p-value less than 0.0001, proving
that at TASO Mulago men begin ART with a significantly lower CD4 cell count
representing later initiation. The results have been summarized in the following table.

22

Based on data collected by the researcher from electronic records at TASO Mulago and
patient files at St. Francis Naggalama Hospital
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Table 4. ANOVA results for CD4 cell count at ART initiation from TASO Mulago23
	
  	
  

N	
  

Mean	
  

Female	
  
Male	
  
Total	
  

960	
  
384	
  
1344	
  

317.5958	
  
250.2708	
  
298.3601	
  

	
  
Between	
  
Groups	
  
Within	
  Groups	
  
Total	
  

Sum	
  of	
  Squares	
  

Std.	
  
Deviation	
  
195.7538	
  
157.4733	
  
188.0441	
  

Std.	
  Error	
  

Minimum	
  

6.317926	
  
8.036024	
  
5.129323	
  

0	
  
2	
  
0	
  

ANOVA	
  
df	
  
Mean	
  Square	
  

1243243	
  

1	
  

1243243	
  

46246009	
  
47489252	
  

1342	
  
1343	
   	
  	
  

34460.51	
  

Maximum	
  
1180	
  
1222	
  
1222	
  

F	
  

	
  p-‐value	
  

36.07731	
   P<0.001	
  
	
  
	
  	
  

	
  
	
  	
  

At St. Francis Naggalama Hospital the researcher followed the same protocol with
a sample size of 240 clients (72 men and 168 women). The average CD4 cell count for
men was 157.89 cells/mm3 and the average CD4 cell count for women was 214.29
cells/mm.3 Results from the one-factor ANOVA revealed a p-value of 0.0019, proving
that at St. Francis Naggalama Hospital men also initiate ART at significantly lower CD4
cell counts. Thus, late initiation based on CD4 cell counts is a common factor at both
facilities. The results have been summarized in the following table.
Table 5. ANOVA results for CD4 cell count at ART initiation from St. Francis
Naggalama Hospital24
	
  
Female	
  
Male	
  
Total	
  

N	
  
168	
  
72	
  
240	
  

	
  
23

Mean	
  
Std.	
  Deviation	
  
Std.	
  Error	
   Minimum	
  	
   Maximum	
  
214.2917	
  
131.0907	
  
10.1139	
  
0	
  
827	
  
157.8889	
  
117.4554	
  
13.8422	
  
3	
  
643	
  
197.3708	
  
129.5258	
  
8.3609	
  
0	
  
827	
  

	
  

ANOVA	
  

	
  

	
  

	
  

Based on data collected by the researcher from electronic records at TASO Mulago
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Based on data collected by the researcher from patient files at St. Francis Naggalama
Hospital
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Between	
  Groups	
  
Within	
  Groups	
  
Total	
  

Sum	
  of	
  
df	
  
Squares	
  
160336.1764	
  
3849353.819	
  
4009689.996	
  

Mean	
  
F	
  
Square	
  
1	
   160336.1764	
  
238	
   16173.7555	
   	
  
239	
   	
  
	
  

p-‐value	
  
9.91	
  

0.001854	
  
	
  
	
  

Using WHO disease stage as another indicator of late initiation, the researcher
found that at TASO Mulago, 7.5 percent of male clients initiated ART at WHO stage 3
and 1.6 percent of men initiated ART at stage 4. At the same facility, 4.6 percent of
women initiated ART at stage 3 and 0.9 percent of women initiated ART at stage 4. At
St. Francis Naggalama Hospital, the researcher found that 22.2 percent of men initiated
ART at stage 3 and 11.1 percent of men initiated ART at stage 4. At the same hospital,
11.3 percent of women initiated ART at stage 3 and 2.4 percent of women initiated ART
at stage 4. The following tables highlight this data.25
Table 6. WHO disease stage numbers of clients at TASO Mulago at ART Initiation
Gender	
  
	
  	
  
Stage	
  1	
  
Stage	
  2	
  
Stage	
  3	
  
Stage	
  4	
  
Total	
  

Female	
   	
  	
  
Male	
   	
  	
  
Total	
   	
  	
  
N	
  
%	
  
N	
  
%	
  
N	
  
%	
  
23	
  
1.0	
  
11	
  
1.2	
  
34	
  
1.0	
  
2,202	
   93.5	
  
810	
   89.7	
   3,012	
   92.4	
  
109	
  
4.6	
  
68	
  
7.5	
  
177	
  
5.4	
  
21	
  
0.9	
  
14	
  
1.6	
  
35	
  
1.1	
  
2,355	
  
100	
  
903	
  
100	
   3,258	
  
100	
  

Table 7. WHO disease stage numbers of clients at St. Francis Naggalama Hospital at
ART initiation26
Gender	
   Female	
   	
  
Male	
  
	
  
N	
  
%	
  
N	
  
Stage	
  1	
  
28	
   16.667	
  
6	
  
Stage	
  2	
  
117	
   69.642	
  
42	
  
Stage	
  3	
  
19	
   11.31	
  
16	
  
Stage	
  4	
  
4	
   2.381	
  
8	
  
Total	
  
168	
  
100	
  
72	
  

	
  
Total	
  
%	
  
	
  
8.333	
  
34	
  
58.333	
  
159	
  
22.222	
  
35	
  
11.111	
  
12	
  
100	
  
240	
  

	
  
%	
  
14.167	
  
66.25	
  
14.583	
  
5	
  
100	
  

25

Based on data collected by the researcher from electronic records at TASO Mulago
Based on data collected by the researcher from patient files at St. Francis Naggalama
Hospital
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While these results indicate that men initiate ART at higher WHO disease stages
than women at both facilities, the researcher utilized another chi-squared test to
determine the statistical significance of these findings. Considering any data with a pvalue less than 0.05 as statistically significant, the researcher found probability values
less than 0.0001 and less than 0.0001 at TASO Mulago and St. Francis Naggalama
Hospital respectively, demonstrating that men initiate ART at significantly higher WHO
disease stages than women at both facilities. The following tables illustrate these
findings.
Table 8. Results of Chi-squared test of WHO disease stages at TASO Mulago and
St. Francis Naggalama Hospital.27
Sample	
  

Variable	
   Observed	
  #	
   Expected	
  #	
   Chi-‐Squared	
  
Value	
  
TASO	
  Mulago	
  
Stage	
  1	
  
11	
  
9.03	
  
22.926	
  
	
  
Stage	
  2	
  
810	
  
844.305	
   	
  
	
  
Stage	
  3	
  
68	
  
41.538	
   	
  
	
  
Stage	
  4	
  
14	
  
8.127	
   	
  
St.	
  Francis	
  Naggalama	
  	
   Stage	
  1	
  
6	
   12.00024	
  
34.95	
  
	
  
Stage	
  2	
  
42	
   50.14224	
   	
  
	
  
Stage	
  3	
  
16	
  
8.1432	
   	
  
	
  
Stage	
  4	
  
8	
  
1.71432	
   	
  

dF	
  

	
  
	
  
	
  
	
  
	
  
	
  

p-‐value	
  

3	
   p<0.0001	
  
	
  
	
  
	
  
3	
   p<0.0001	
  
	
  
	
  
	
  

Findings and Discussion
After testing those hypotheses as a basis for the study, the researcher collected
and analyzed qualitative data to determine the reasons for these significant differences in
mortality rate, CD4 cell count, and WHO disease stage numbers between men and
women in Uganda. The researcher analyzed differences in perceptions of HIV testing,
antiretroviral treatment and circumcision programs as well as differences in opportunities
for men and women to engage in provider-initiated HIV/AIDS care and support to
understand why each facility had significantly more women than and to determine why
men initiate ART later than women. The findings for these critical aspects of
27

Based on data collected by the researcher from the electronic records at TASO Mulago
and patient files at St. Francis Naggalama Hospital
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comprehensive HIV/AIDS care will be explored in further detail in the following
sections.

Reasons and Motives for HIV Testing
The researcher found a significant difference in the reasons men and women seek
HIV testing. Based on focus group discussions the majority of clients at TASO Mulago
and St. Francis Naggalama Hospital test for HIV as a result of Routine Counseling and
Testing (RCT). Most healthcare facilities highly encourage patients to test for HIV at the
sign of illness to insure proper treatment for the ailment that they are diagnosing. Most
clients that the researcher interviewed entered a healthcare facility to seek treatment for
some illness and tested for HIV under this RCT method. The researcher found that 23 of
the 50 men interviewed at TASO tested for HIV for this reason while 25 of the 67 women
interviewed tested under this method. At St. Francis Naggalama Hospital 17 of 20 men
interviewed used RCT as a testing method while 13 of the 20 women interviewed
followed the same protocol. The difference in motivations for HIV testing resulted in a
law insisting that women test for HIV during pregnancy. The researcher found that 14 of
67 women at TASO Mulago tested for HIV as a result of this law while only 1 of 20
women at St. Francis Naggalama Hospital tested under this same principle. Men do not
have a similar avenue to test for HIV and, as a result, men are more likely to test for HIV
once the harmful effects of the virus begin to show. This results in lower CD4 cell counts
and higher WHO disease stages as noted earlier, resulting in a higher mortality rate for
men as they initiate ART as well as a smaller number of men being engaged in
HIV/AIDS care.
This law also explains the larger number of women engaged in antiretroviral
treatment services. To properly combat HIV prevalence, healthcare facilities must engage
men in HIV/AIDS testing services before the virus begins to show symptoms. The
Human Immunodeficiency Virus can remain in the human body for decades before
symptoms begin to show.28 This high prevalence not only gives men in Uganda a large
window of time to transmit the virus without any knowledge of its prevalence in their
28
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body but also puts the health of hundreds of thousands of men in Uganda at risk. A
proper HIV/AIDS care strategy must be able to limit this level of prevalence to protect
the health and well being of the citizens of this country and an avenue for earlier HIV
testing for men is the first step to accomplishing this task.
Community sensitization and counseling services could provide an avenue for
men to engage in HIV/AIDS care at earlier stages of HIV infection. Clients in focus
group discussions insisted that men are often too stubborn or too busy to test for HIV.
According to a counselor at TASO, the notion of being sick makes men feel weak which
is highly discouraged in Ugandan culture.29 Therefore, promoting HIV testing for men
becomes a lot more difficult because of these cultural and social factors. The counselor
insisted that skits and plays prove very effective in educating vulnerable groups about the
dangers of HIV and the benefits of HIV testing. Effective sensitization can impact these
social and cultural factors so that men feel encouraged to test though many men will
discover their status and change no aspect of their lives out of fear of weakness. They do
not inform their partners of their status, they hide the news from their families and
friends, and they simply wait to die from the complications of AIDS. The counselor
insisted that men often have a saying that “what I don’t know won’t hurt me but what I
do know can hurt me.” The values in this saying drive a lot of the decisions that men in
Uganda make about whether or not to test for HIV or if treatment is worthwhile. These
social and cultural barriers to male engagement in HIV testing services suggest that while
sensitization and counseling have provided great results in promoting effective HIV care,
other avenues are necessary to promote more men to test for HIV services.
Many individuals in focus groups argued for mandatory HIV testing for all men
but the counselor urged that this strategy would create more harm than good. She insisted
that men should have the right to chose and forcing them to test for HIV will not
effectively cross the social and cultural barriers to sensitization and counseling. Men
must become interested and invested in their own health for true change to occur. Proper
investment includes following treatment regimes, sharing knowledge of status with
sexual partners, and eliminating transmission of the virus through safe sex and
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contraception. The counselor stated that forcing men to test only solves one part of a
large puzzle, suggesting that knowing one’s status is not enough. Joining in the fight
against the prevalence of transmission is everyone’s responsibility and this is only
possible through constant engagement in comprehensive HIV/AIDS care strategies.

Antiretroviral Treatment Services
Focus group discussions also provided the researcher with social and cultural
factors affecting initiation and adherence to antiretroviral treatment. Many respondents in
these focus groups stated that they were scared to take antiretroviral treatment because of
various rumors suggesting that ARV’s were created to kill those living with HIV to
eliminate the possibility of transmission. Stigma surrounding the use of antiretroviral
medication and treatment creates another barrier to proper HIV/AIDS care. Without
mandatory HIV testing for men, the critical step of persuading men to engage in
HIV/AIDS care strategies with such rumors becomes extremely difficult. Sensitization
and counseling services must prevent such rumors from spreading. Antiretroviral
treatment has been an affordable and essential aspect of the battle against HIV/AIDS by
promoting life in the midst of HIV infection and initiation of this treatment must not be
hindered. This social factor also encourages the later initiation of men on antiretroviral
treatment discussed earlier. Women must adhere to these medications during pregnancy
but men can refuse to begin or adhere to these medications, especially those living with
the belief that ART is designed to kill them. Proper education must be established to
inform individuals holding this belief of the proper purpose and good intent of ART
programs in Uganda.
Some respondents also suggested timing as a reason for lack of men testing for
HIV and late initiation of antiretroviral treatment. Many clients at both TASO Mulago
and St. Francis Naggalama Hospital spend the majority of their day waiting to receive
medication and counseling services. An interview with Dr. Simon Sentumbwe revealed
that many men have jobs in which they cannot leave for such a long time.30 He insisted
that many men must rely on private facilities because government facilities are
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overcrowded, resulting in a large waiting time. Dr. Sentumbwe encouraged more public
private partnership (PPP) to allow for government-sponsored hospitals to limit waiting
times while providing private facilities with more affordable medication, resulting in a
larger audience. While the large time commitment necessary for proper health should be
considered a sound investment, facilities can play a greater role in decreasing waiting
times to promote greater interest and adherence to all forms of HIV/AIDS care, especially
antiretroviral therapy.
Many respondents also indicated that poverty takes a huge toll on adherence to
antiretroviral medication. According to Dr. Simon Sentumbwe, taking the medication
requires a significant amount of water and the human body responds to the side effects of
the medication better when the medicine is taken with a full meal. Antiretroviral
treatment itself is affordable and even free at some institutions like TASO but proper
adherence and avoidance of caustic side effects requires consistent access to food and
water, which many clients simply do not possess. Respondents in focus groups have
reported that this lack of access to food and water creates severe side effects such as
hallucinations, skin rashes, and even temporary paralysis. While these side effects cause
great trauma to an individual, they also create stigma around the use of antiretroviral
medication, causing many people to believe in rumors such as the one stated in the
previous paragraph. Once again, this finding discourages men from initiating and
adhering to antiretroviral medication, leading to a higher mortality rate among men once
they actually initiate ART.
Finally, the life-changing effects of antiretroviral medication can do more harm
than good. Based on an interview with a pharmacist at St. Francis Naggalama Hospital,
many individuals believe that ARVs have cured their HIV status even though it only
addresses the symptoms.31 As a result they become sexually active and can potentially
transmit the virus even though their harsh symptoms may disappear. Cultural norms
permit men in particular to participate in polygamy so that this transmission can lead to a
large number of partners becoming infected with the virus. Sensitization and education
can each play a huge role in this aspect of HIV/AIDS care by informing people that
transmission of HIV is still probable for individuals taking antiretroviral medication. As
31
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stated earlier, comprehensive HIV/AIDS care strategies create the best opportunity to
combat HIV prevalence (See Appendix B). Thus, simply taking medication or testing for
HIV are each critical preliminary steps to eliminating HIV from the country of Uganda
but proper adherence to all aspects of comprehensive HIV/AIDS care including
counseling, proper utilization of medication, sharing knowledge of one’s status and using
contraception are all valuable and essential to combating HIV/AIDS prevalence. Forcing
an individual to participate in one aspect of care will not prove effective. To fully
eliminate gender disparities in access to comprehensive HIV/AIDS care requires that men
fully engage in all aspects of HIV/AIDS care to join the fight to lower the prevalence of
this virus from the country of Uganda. Based on these findings, the researcher proposes
greater implementation of male circumcision programs to provide men in Uganda with
the best opportunity to engage in comprehensive, provider-initiated HIV/AIDS care.

Male Circumcision Programs as Avenues of Engagement
As stated earlier, implementation of circumcision programs would provide an
avenue for men to test for HIV similar to the avenue women have through pregnancy and
antenatal services. Based on focus group discussions, 35 of 50 men were not circumcised
at TASO Mulago and 15 of 20 men at St. Francis Naggalama Hospital were not
circumcised. Implementation of circumcision programs would benefit a large percentage
of the population of men in Uganda by reducing their risk of contracting all STI’s and by
engaging them in HIV care. Based on focus group discussions, social and cultural factors
also create stigma on this issue. The Muslim faith encourages all individuals in their faith
to circumcise at an early age but many men of other religions feel as if they should be
excluded from this act if they are not Muslim. One respondent indicated that political
leaders of Muslim faith have attempted to encourage safe male circumcision but they
have met their fair share of opposition because of their faith. A large number of people
felt that this was an attempt to convert the entire country to the Muslim faith rather than
an attempt to expand the health benefits of male circumcision. Community sensitization
must be implemented in these programs to combat stigma and encourage people of all
faiths to engage in this aspect of HIV/AIDS care.
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Circumcision programs are currently in place but they come with a fair share of
flaws. Many respondents in focus group discussions stated that they feared circumcision
because they only have access to government-sponsored hospitals in which patients only
receive painkillers. Improper treatment of the wound resulting from circumcision surgery
can result in severe complications that hinder a man’s ability to function in daily tasks.
Some men have seen father figures and relatives die from the complications of
circumcision because of a lack of proper treatment and, as a result, they refuse to become
circumcised. Proper treatment comes from proper funding and lately donor and
government funding has decreased for male circumcision programs according to Dr.
Sentumbwe. Many outside benefactors understand the health benefits of the act of
circumcision but using male circumcision programs as avenues for greater male access to
comprehensive HIV/AIDS care services provides greater justification as to why these
programs should be funded further.
Makerere University initiated a safe male circumcision program that targets
young men in an attempt to provide men with an accessible method of circumcision.
Based on an interview with faculty at this circumcision facility, circumcisions are
performed within an hour of patients arriving after a series of educational talks about the
benefits of circumcision.32 Yet, this facility offers very little sensitization and treatment.
Painkillers are administered after the surgery with instructions on how to handle the
wound but based on focus group discussions these tactics still instill fear into a majority
of men who are in need of the services.
Through enhanced male circumcision programs men would receive sensitization
about the problem of HIV/AIDS in Uganda as well as counseling on the proper steps to
live functionally with the virus while taking the responsibility of aiding in the fight
against HIV/AIDS prevalence. Education about antiretroviral treatment and its effects,
proper contraception and abstinence, and disclosure to partners would all result from the
act of circumcision, which already plays a role in decreasing HIV/AIDS transmission.
Proper treatment must also be administered as well as referral to a facility with the
resources necessary to provide all aspects of antiretroviral therapy services. Based on
findings from this study, the majority of men living with HIV have not been circumcised,
32

Interview Nurse, Safe Male Circumcision Clinic, Kampala, Uganda 8 November 2013
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suggesting that a large number of men living with HIV in Uganda have not only refused
to test for HIV based on the findings discussed earlier but also have not been
circumcised. The potential audience for these programs is massive but proper funding
must become a reality for proper implementation of these programs. Full engagement of
men in comprehensive HIV/AIDS care can be achieved and an enhanced male
circumcision program is the first step.

Rural vs. Urban Comparison
Throughout this practicum period, the researcher noticed some substantial
differences in HIV/AIDS care in rural and urban areas. First of all, the mortality rates
established at St. Francis Naggalama Hospital are much higher for both genders than the
mortality rates at TASO (69.4 deaths per 1000 men and 23.8 deaths per 1000 women at
St. Francis Naggalama Hospital versus 16.5 deaths per 1000 men and 11.1 deaths per
1000 women at TASO Mulago). Average CD4 values were also much lower at St.
Francis Naggalama Hospital (157.9 cells/mm3 for men and 214.3 cells/mm3 for women
versus 250.3 cells/mm3 for men and 317.6 cells/mm3 for women at TASO Mulago) while
more clients exhibited a stage 3 or stage 4 WHO disease stage. Many individuals in rural
areas do not have the same access to healthcare facilities and as a result they prolong
initiation of ART even longer. Men in rural areas feel the effects of this fact most of all
because they have multiple factors contributing to their late initiation, resulting in their
substantially higher mortality rate (69.4 deaths per 1000 men). As a result men in rural
areas were much more likely to test for HIV through the RCT method (17 out of 20 men).
Men already have less access to comprehensive HIV/AIDS care and the rural setting
further perpetuates this lack of access. Based on observations, the researcher found that
many male clients at St. Francis Naggalama Hospital often missed appointments but
followed up later at a random date to receive care. These delays signify the level of
access these men have to access treatment. Their persistence to arrive at a later date
suggests that they desire treatment and value their health but they often cannot engage at
the proper timing. The researcher also noticed a substantial amount of men transferring to
other facilities to increase access to HIV/AIDS services. This step plays a great role in
efforts to engage men as well as in battling HIV prevalence all over the country. Greater
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effort to involve men in HIV/AIDS care must be universalized for the entire country to
access. A holistic approach is necessary to fully combat HIV/AIDS prevalence and
universal access to these services involves those in urban and rural settings equally.

Conclusions
Based on the findings, the researcher has drawn conclusions based on the
objectives of the study.
Objective 1: To assess if there are gender differences in access to HIV testing and
antiretroviral treatment services.
The researcher found numerous gender differences in HIV/AIDS care access.
Results from the statistical analysis prove that men are more likely to die upon initiation
of antiretroviral treatment. These results also indicate that men begin antiretroviral
treatment at significantly lower CD4 cell counts and significantly higher WHO disease
stage numbers, both of which emphasize later initiation of antiretroviral treatment. Using
qualitative data to supplement these results, the researcher found differences in
perception, adherence, and ultimately, opportunity to access comprehensive HIV/AIDS
care, which will be explored in the next objective.
Objective 2: To further examine the causes of disparities between men and women in
access to HIV prevention and treatment
Most participants interviewed in focus group discussions began HIV/AIDS care at
the sign of symptoms of HIV infections, which can occur up to decades after initial HIV
infection. Women often engaged in care as a result of pregnancy and without a similar
avenue, the vast majority of men only accessed treatment and support as a result of grave
illness. This finding explains the lower CD4 cell counts and higher WHO disease stages
observed in the results section. Men require an avenue for provider-initiated HIV testing
similar to women that informs them of their HIV status before symptoms begin to show.
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Men struggle with stigma surrounding HIV testing and treatment services. Men
view themselves as weak for testing for HIV or acknowledging their status. Therefore
they often refuse to test or they never disclose their HIV status to their sexual partners.
Other rumors also discourage men from seeking HIV/AIDS treatment such as the notion
that ARVs were invented to kill all people with HIV to eliminate its transmission.
Poverty also causes the harmful side effects of ARVs to plague those initially taking the
medication. Other men see these side effects and, as a result, feed into the rumors and
stigma surrounding this treatment.
Objective 3: To establish the differences in mortality rate between men and women upon
their initiation of antiretroviral treatment
Electronic records at TASO Mulago and patient files from St. Francis Naggalama
Hospital provided the researcher with the necessary data to establish the mortality rate of
men and women at each facility. At TASO Mulago the mortality rate was 16.485 deaths
per 1000 men and 11.13 deaths per 1000 women. At St. Francis Naggalama Hospital the
mortality rate was 69.444 deaths per 1000 men and 23.809 deaths per 1000 women.
Through this data, the researcher tested and proved the hypothesis that men initiate ART
at higher mortality rates based on the facilities the researcher utilized.
Objective 4: To compare HIV treatment, counseling, and antiretroviral treatment services
for men in urban and rural facilities in Uganda.
Based on observations and statistical analysis, the researcher concluded that living
in a rural area creates even less opportunities for men and women to engage in
HIV/AIDS care. As established in the previous objective, the mortality rate for men and
women was higher at St. Francis Naggalama Hospital than at TASO Mulago. Men in
particular had a much higher mortality rate at 69.444 deaths per 1000 men. Expanding on
this fact, the average CD4 cell count for men at St. Francis Naggalama (157.9 cells/mm3)
was much lower than at TASO Mulago (250.3 cells/mm3). CD4 cell counts lower than
350 cells/mm3 are considered significantly low, so the data from St. Francis Naggalama
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is alarming. These men have very few opportunities to engage in HIV/AIDS care because
they lack a proper avenue for provider-initiated HIV testing and they live in a rural area
with lack of access to proper facilities for treatment. Many men often missed their formal
appointment date to return on a different day, suggesting that men are interested in
engaging in treatment and support but access is quite limited.
Objective 5: To propose methods to increase opportunities for men to engage in providerinitiated HIV testing.
The researcher proposed that enhanced male circumcision programs provide the
best method of increasing opportunity to engage in provider-initiated HIV testing. This
method involves sensitization and education about HIV/AIDS prevalence and
transmission, HIV testing, circumcision, and referral to a facility with proper resources
for those infected with HIV. All of these aspects are critical to combating HIV/AIDS
prevalence in Uganda and forcing men to engage in any one aspect alone will not
empower them to want to make a difference in the prevalence of this epidemic.
Encouragement and support through this avenue of provider-initiated testing are the best
methods of engaging men more in the fight against HIV/AIDS.

Recommendations
Based on findings throughout this practicum period, the researcher proposes the
following recommendations. Global efforts to eliminate PMTCT have been extremely
effective but this effort needs to provide more focus on men living in Uganda with
HIV/AIDS. As stated earlier, 80 percent of new cases of HIV result from heterosexual
contact as opposed to PMTCT, which results in 20 percent of new cases. Both methods of
transmission need to be addressed thoroughly but if the same level of attention posed
toward PMTCT was directed towards men in the fight against HIV/AIDS prevalence and
transmission then the great strides that have significantly reduced PMTCT can also
significantly reduce heterosexual transmission.
While many individuals recommend mandatory HIV testing for men through
various methods, the researcher recommends the opposite. Forcing men to engage in one
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aspect of HIV/AIDS treatment will not effectively combat all of the social and cultural
forces that stigmatize HIV testing and treatment. Forcing men to test will not encourage
them to seek treatment or disclose their status to their sexual partners. Healthcare
facilities must promote interest in the area of HIV/AIDS transmission and prevalence.
Every citizen of Uganda can play a role in the battle against HIV/AIDS. Proper
encouragement will lead to significant interest and, as a result, a large majority of
Ugandan citizens can make great steps to ending this epidemic.
This global effort should place emphasis on Safe Male Circumcision Programs.
Current programs do not have the resources to properly sensitize the community to
combat the stigma surrounding HIV testing and male circumcision. These programs
would provide a great avenue for men to engage in all facets of comprehensive
HIV/AIDS care and support. Proper funding and support for these programs would
insure that men become educated about the problem of HIV/AIDS in Uganda and
encourage that interest mentioned earlier. Yet, testing and circumcision represent the
initial steps to proper implementation of these programs. Referrals should be made for
clients based on location and facilities must continue to provide counseling and adequate
treatment. The effectiveness of these programs relies on all of these aspects working
efficiently and collectively to promote the reduction of HIV/ AIDS prevalence.
Political leaders should continue to encourage the men of Uganda to engage in
comprehensive HIV/AIDS care and support. This act should be highly celebrated as a
strong, responsible action for all men to become involved in. Media also plays a great
role in this step. Men should feel empowered through the act of circumcision and HIV
testing rather than weak and vulnerable. Combating rumors and stigma is just as
significant as combating HIV transmission and the individuals responsible for
empowering the community can effectively decrease the power of stigma in relation to
concerns of male engagement in HIV/AIDS care.
Everyone feels the effects of HIV prevalence in Uganda and, as a result, everyone
must play a role in eliminating this prevalence. Many individuals have lost their lives to
complications from this virus and many people have lived in fear of exposing themselves
to this condition. The time has come to mobilize the entire population of Uganda to join
in this fight. Great strides have been made to decrease the effects of this epidemic.
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Educating and involving men, women, and children creates unity and unity is absolutely
required to eradicate this epidemic from Uganda and the planet. UNAIDS and the rest of
the world can achieve universal access to HIV services but the next step is involving and
engaging men in this goal. “Getting to zero” is the goal promoted by UNAIDS and with
unity it is only a matter of time before this goal is realized.
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Appendix
A.

Figure 1. HIV Prevalence by Region in Uganda
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B.

Figure 2. Impact of three scenarios on HIV infection in sub-Saharan Africa, 2003-2020.
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C.
Questionnaire for Focus Group Discussions Version 3.0
Age:
Gender:
Married (Yes or No):
Occupation:

1. What motivated you to test for HIV?
2. Does your partner know his/her status?
3. Did/do you encourage your partner to get tested?
4. Has a hospital ever insisted that you take a HIV test? If so, at when did they insist
that you test for HIV?
5. Why don’t more men test for HIV?
6. How can we get more men to test for HIV?
7. What motivated you to take antiretroviral medication?
8. What specific antiretroviral medication do you take?
9. What challenges do you face while taking antiretroviral medication?
10. Do you feel that the medication is helping? Why or why not?
11. (For men) Are you circumcised?
a. If yes: Did you get circumcised at a hospital or using traditional means?
b. If no: Has a hospital ever encouraged you to get circumcised?
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D.

46
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E.
Interview Schedule for TASO Counselor at TASO Mulago Version 3.0
1. Can you explain how the sensitization and counseling process works?
2. Do you feel that men respond differently to these methods?
3. Are people generally receptive to these sensitization strategies?
4. Why is there such a lack of men engaged in antiretroviral treatment in this
facility?
5. What rumors do you typically have to address concerning HIV testing or ARVs?
6. Do you think that ARVs are effective as a method of treatment?
7. Do you find any differences between how men respond to ARVs?
8. Do you think circumcision programs would create an avenue for men to engage in
comprehensive HIV/AIDS care?
9. Should laws exist that insure mandatory HIV testing for men?

Interview Schedule for Dr. Simon Sentumbwe Version 3.0
1. Why don’t more men test for HIV?
2. How can we combat the stigma around men testing for HIV/AIDS?
3. Can you describe in detail some past male circumcision programs?
4. Why did these programs end?
5. What do you think is the best strategy to better engage men in comprehensive
HIV/AIDS services?
6. Many clients at TASO Mulago complained about improper treatment after
circumcision. Can you describe what they may be referring to?
7. Should laws exist that insure mandatory HIV testing for men?
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8. Do you think circumcision programs would create an avenue for men to engage in
comprehensive HIV/AIDS care?

Interview Schedule for Nurse at Makerere Circumcision Clinic Version 3.0
1. Do you know how this clinic got started?
2. Can you elaborate on your community sensitization methods?
3. Many clients at TASO Mulago complained about improper treatment after
circumcision. Can you describe what they may be referring to?
4. What process does a typical client experience at this clinic?
5. How long does the wound from circumcision take to heal?
6. Do you test for HIV before performing the surgery?
7. Should laws exist that insure mandatory HIV testing for men?
8. Do you think circumcision programs would create an avenue for men to engage in
comprehensive HIV/AIDS care?

Interview Schedule for Pharmacist at St. Francis Naggalama Hospital Version 3.0
1. How long have you worked at St. Francis Naggalama Hospital?
2. Have ARVs changed over your duration of working here?
3. Do you think that ARVs are effective as a method of treatment?
4. Do you find any differences between how men respond to ARVs?
5. Should laws exist that insure mandatory HIV testing for men?
6. Do you think circumcision programs would create an avenue for men to engage in
comprehensive HIV/AIDS care?
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F.
CONSENT FORM
The purpose of this study is to gain a better understanding of Antiretroviral Treatment in
Uganda, specifically how men and women respond to this treatment differently. This
study also hopes to test the hypothesis that men initiate antiretroviral treatment later than
women. Finally, this study will attempt to propose methods for more provider-initiated
HIV testing for men.
Rights Notice
In an effort to uphold the ethical standards of all SIT ISP proposals, this study has been
reviewed and approved by a Local Review Board or SIT Institutional Review Board. If at
any time, you feel that you are at risk or exposed to unreasonable harm, you may
terminate and stop the interview. Please take some time to carefully read the statements
provided below.
a. Privacy – all information you present in this interview may be recorded an
safeguarded. If you do not want the information recorded, you need to let the
interviewer know.
b. Anonymity – all names in this study will be kept anonymous unless the
participant chooses otherwise.
c. Confidentiality – all names will remain completely confidential and fully
protected by the interviewer. By signing below, you give the interviewer full
responsibility to uphold this contract and its contents. The interviewer will
also sign a copy of this contract and give it to the participant.
__________________________
Participant’s name printed

_____________________________
Participant’s signature and date

__________________________
Interviewer’s name printed

_____________________________
Interviewer’s signature and date

For any questions or concerns please contact:
Wyatt Lombard Smith
Telephone: 0793938602
E-mail: wsmith7@nd.edu

Charlotte Mafumbo
Telephone: 0794518549
E-mail: charlotte.mafumbo@sit.edu
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Demographic Information from Focus Group Discussions
Chart 1. Age Groups of Men at Each Facility
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Chart 2. Age Groups of Women at Each Facility
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Chart 3. Percentage of Clients’ Marriage Status at Each
Facility
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Chart 4. Motivations for HIV Testing
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Chart 5. Circumcision Survey
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